Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCMVENT
Stock Latest News
Private Companies
Early Phase Data for STORM Therapeutics’ METTL3 Inhibitor Signals Potential in Sarcoma
6h ago
MVENT
Premium
Private Companies
Early-Stage Sarcoma Data Highlight Potential of STORM Therapeutics’ METTL3 Inhibitor
12h ago
MVENT
Premium
Private Companies
M Ventures – Weekly Recap
3d ago
MVENT
Premium
Private Companies
Boehringer Ingelheim Licenses Immunitas Antibody Program in Deal Worth Up to €407.5 Million
6d ago
MVENT
Premium
Private Companies
Digital NeuroMarker Focus Puts Altoida in Spotlight Within M Ventures Healthtech Portfolio
6d ago
MVENT
Premium
Private Companies
Boehringer Ingelheim Licenses Immunitas Antibody Program in €407.5 Million Deal
6d ago
MVENT
Premium
Private Companies
M Ventures – Weekly Recap
24d ago
MVENT
Premium
Private Companies
Theolytics Advances THEO-260 Into U.S. Phase 1 Trial for Resistant Ovarian Cancer
28d ago
MVENT
Premium
Private Companies
Theolytics Advances THEO-260 Into Second Clinical Trial for Platinum-Resistant Ovarian Cancer
28d ago
MVENT
Premium
Private Companies
M Ventures – Weekly Recap
1M ago
MVENT
Premium
Private Companies
Lightcast Secures $27 Million Financing to Advance Envisia Single-Cell Platform
1M ago
MVENT
Premium
Private Companies
Lightcast Financing Round Signals Expansion Potential for M Ventures’ Portfolio
1M ago
MVENT
Premium
Private Companies
STORM Therapeutics Raises $56 Million Series C to Advance METTL3 Inhibitor Program
1M ago
MVENT
Premium
Private Companies
STORM Therapeutics Raises $56 Million Series C to Advance Oncology Candidate
1M ago
MVENT
Premium
Private Companies
M Ventures Highlights Focus on Bio–Semiconductor Convergence at Bioconvergence Conference
1M ago
MVENT
Premium
Private Companies
M Ventures Highlights Focus on Bioconvergence and Tech-Enabled Bio Investing
1M ago
MVENT
Premium
Private Companies
M Ventures Strengthens Tech Investment Team With AI-Focused Director Hire
2M ago
MVENT
Premium
Private Companies
M Ventures Strengthens Tech Investment Team With AI-Focused Director Hire
2M ago
MVENT
Premium
Private Companies
M Ventures Highlights Deep-Tech Networking Focus at OFC 2026
2M ago
MVENT
Premium
Private Companies
M Ventures Deepens Photonics and Optical Communications Focus at OFC 2026 Networking Event
2M ago
MVENT
Premium
Private Companies
ReproNovo Strengthens Governance With Appointment of New Chairman
2M ago
MVENT
Premium
Private Companies
Industry Recognition Underscores Investment Talent at M Ventures
2M ago
MVENT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
